News | January 24, 2007

Statins Not Helping Women

Jan. 25, 2007 — Research emerging this week from a Harvard researcher claims there is no evidence that statins prevent heart disease in women. In addition, data suggest that men over 69 with only moderate risk of future heart problems are not benefited by taking statins either.

The drugs should no longer be regularly prescribed to these populations, according to the finding from Dr. John Abramson, Harvard Medical School, and Dr. James M. Wright, from the University of British Columbia.

Other experts are disputing the research, maintaining that good evidence exists that statins reduce heart disease and deaths from heart attacks. The drugs are designed to reduce levels of bad cholesterol called LDLs which can fur up the arteries and lead to heart disease.

"Statins did not reduce total coronary heart disease events in 10,990 women in these primary prevention trials," the researching physicians said. "Similarly in 3,239 men and women older than 69 years, statins did not reduce total cardiovascular events.”
"Our analysis suggests that lipid-lowering statins should not be prescribed for true primary prevention in women of any age or for men older than 69 years."


Related Content

News | Pharmaceuticals

Sept. 25, 2025 — Kardigan has introduced the three late-stage clinical programs leading its robust pipeline, each ...

Home September 25, 2025
Home
News | Pharmaceuticals

Sept. 23, 2025 — CeleCor Therapeutics’ multinational Phase 3 clinical trial of its investigational heart-attack drug ...

Home September 23, 2025
Home
News | Pharmaceuticals

Sept. 2, 2025 —Corsera Health, Inc. has announced its launch with a mission to extend healthspan through cardiovascular ...

Home September 05, 2025
Home
News | Pharmaceuticals

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

Home July 10, 2024
Home
News | Pharmaceuticals

June 5, 2024 — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data ...

Home June 05, 2024
Home
News | Pharmaceuticals

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...

Home May 24, 2024
Home
News | Pharmaceuticals

May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...

Home May 06, 2024
Home
News | Pharmaceuticals

February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on ...

Home February 16, 2024
Home
News | Pharmaceuticals

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
Subscribe Now